Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a global financial intelligence and recognition platform delivering authoritative insights, data-driven analysis, and institutional benchmarking across Banking, Capital Markets, Investment, Technology, and Financial Infrastructure. Global Banking & Finance Review® operates a Digital-First Banking Awards Program and framework — an industry-first digital only recognition model built for the modern financial era, delivering continuous, transparent, and data-driven evaluation of institutional performance.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Finance > Exor, founder sell Italian private healthcare group Lifenet to insurer Reale Mutua
    Finance

    Exor, founder sell Italian private healthcare group Lifenet to insurer Reale Mutua

    Published by Global Banking & Finance Review®

    Posted on February 16, 2026

    2 min read

    Last updated: February 16, 2026

    Exor, founder sell Italian private healthcare group Lifenet to insurer Reale Mutua - Finance news and analysis from Global Banking & Finance Review
    Tags:insurancehealthcarepartnershipinvestmentacquisition

    Quick Summary

    Exor and Lifenet founder sell the healthcare group to Reale Mutua for 600 million euros, highlighting a trend in insurer-healthcare partnerships.

    Table of Contents

    • Overview of the Lifenet Healthcare Acquisition
    • Details of the Transaction
    • Market Trends in Healthcare Partnerships
    • Role of Financial Advisors

    Exor and Founder Divest Italian Healthcare Group Lifenet to Reale Mutua

    Overview of the Lifenet Healthcare Acquisition

    MILAN, Feb 16 (Reuters) - Exor, the Agnelli family's investment vehicle, and the founder of Lifenet Healthcare have agreed to sell the Italian private clinics and diagnostics group to insurer Reale Mutua, the companies said on Monday.

    Details of the Transaction

    Lifenet Healthcare, which runs private hospitals, eye and dental clinics across several Italian regions, said in a joint statement with Reale Group it expected revenues of more than 450 million euros ($533 million) this year.

    Market Trends in Healthcare Partnerships

    Insurers are increasingly partnering with private healthcare groups as both sides strive to keep costs in check and attract more patients.

    Role of Financial Advisors

    Reale Mutua is acquiring 80% of Lifenet, with founder Nicola Bedin retaining 20% through the family's holding company Invin.

    The transaction values Lifenet Healthcare at around 600 million euros, a person close to the matter said, adding the sale had attracted strong interest from both industrial players and investment funds.

    "Reale Group is the ideal investor for Lifenet," Bedin said.

    The accord is the latest evidence of intense dealmaking in health services, where insurers, private equity firms and healthcare groups are increasingly teaming up, with a focus on outpatient clinics, day-surgery centres and diagnostic services.

    JPMorgan acted as lead financial adviser on the deal, working with Exor and Invin. ($1 = 0.8439 euros)

    (Reporting by Valentina Za; Editing by Lisa Shumaker)

    Key Takeaways

    • •Exor and Lifenet founder sell to Reale Mutua.
    • •Lifenet valued at 600 million euros.
    • •Reale Mutua acquires 80% stake.
    • •Healthcare partnerships are on the rise.
    • •JPMorgan acted as lead financial adviser.

    Frequently Asked Questions about Exor, founder sell Italian private healthcare group Lifenet to insurer Reale Mutua

    1What is an acquisition?

    An acquisition occurs when one company purchases most or all of another company's shares to gain control of that company.

    2What is a financial advisor?

    A financial advisor is a professional who provides financial services and advice to clients, helping them manage their investments and financial planning.

    3What is revenue in business?

    Revenue is the total income generated from the sale of goods or services before any expenses are deducted.

    4What is insurance?

    Insurance is a financial product that provides protection against financial loss or risk, typically in exchange for regular premium payments.

    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    More from Finance

    Explore more articles in the Finance category

    Image for Citi says geopolitics to support oil near term; peace deals seen lowering prices
    Citi says geopolitics to support oil near term; peace deals seen lowering prices
    Image for French star Isabelle Huppert revels in vampire role with 'The Blood Countess'
    French star Isabelle Huppert revels in vampire role with 'The Blood Countess'
    Image for Third Point buys stake in Spanish defence firm Indra, source says
    Third Point buys stake in Spanish defence firm Indra, source says
    Image for Nexperia to receive $60 million loan from Invest International to boost chip output
    Nexperia to receive $60 million loan from Invest International to boost chip output
    Image for Portugal says efforts to balance budget, cut debt constrained by storm damage
    Portugal says efforts to balance budget, cut debt constrained by storm damage
    Image for Westinghouse to increase headcount in Spain as it eyes growth in Europe
    Westinghouse to increase headcount in Spain as it eyes growth in Europe
    Image for Italian prosecutors open BFF Bank false accounting probe, sources say
    Italian prosecutors open BFF Bank false accounting probe, sources say
    Image for Siemens Energy investors say wind unit spin-off is premature
    Siemens Energy investors say wind unit spin-off is premature
    Image for UK government drops plans to delay May council votes, adding to pressure over U-turns
    UK government drops plans to delay May council votes, adding to pressure over U-turns
    Image for EU countries must not hide behind national interests, German minister says
    EU countries must not hide behind national interests, German minister says
    Image for Aberdeen to vote against $9.2 billion FedEx-led InPost takeover
    Aberdeen to vote against $9.2 billion FedEx-led InPost takeover
    Image for Bank of England to cut rates in March, timing of further cuts unclear: Reuters poll
    Bank of England to cut rates in March, timing of further cuts unclear: Reuters poll
    View All Finance Posts
    Previous Finance PostCiti says geopolitics to support oil near term; peace deals seen lowering prices
    Next Finance PostFrench star Isabelle Huppert revels in vampire role with 'The Blood Countess'